News and innovation April 29, 2024
EU Directive 2022/431: What’s in it for healthcare workers?
EU Directive 2022/431 in a nutshell European Union (EU) Directive 2022/431, also known as the Carcinogens, Mutagens and Reprotoxic Substances…
EU Directive 2022/431: What’s in it for healthcare workers?
EU Directive 2022/431 in a nutshell European Union (EU) Directive 2022/431, also known as the Carcinogens, Mutagens and Reprotoxic Substances…
Earth Day 2024: Our planet prefers TIVA anaesthesia—do you?
Healthcare's climate footprint is equivalent to 4.4% of global net emissions; this means that if the health sector were a…
Reducing infection with catheter care bundles
Catheter-related bloodstream infections (CRBSIs) are a serious threat to patients with a vascular access device, yet many are preventable using…
Scientific evidence on VATs: Is there enough? Is it robust?
There is much scientific evidence available on the efficacy of vascular access teams (VATs) in managing costs, preventing intravenous (IV)…
BD IV News 2.0: building an IV therapy community
Your source of information on IV therapy just got a whole lot better. Following feedback from readers, BD IV News…
Device and drug shortages in Europe persist, new survey shows
Countries across the globe face a wide range of challenges in accessing necessary health products, such as shortages and stockouts.1…